You’ve probably heard of the semaglutide brand names Ozempic®, Wegovy, and Rybelsus. You may have even heard about affordable options like compounded semaglutide.
A new study has revealed that people who consume Ozempic or similar medications to treat diabetic/weight-related conditions are less likely to opioid overdose and alcohol abuse.
Provisional data from the CDC indicates a 15% drop from the prior 12-month period. Separately, accidental overdoses of fentanyl in San Francisco dropped to a four-year low in September.